MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.

Songming Ding , Guoliang Chen , Wu Zhang , Chunyang Xing
Journal of Translational Medicine 13 ( 1) 237 -237

36
2015
Molecular Determinants of Cetuximab Efficacy

Daniel Vallböhmer , Wu Zhang , Michael Gordon , Dong Yun Yang
Journal of Clinical Oncology 23 ( 15) 3536 -3544

302
2005
Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

Armin Gerger , Anthony El-Khoueiry , Wu Zhang , Dongyun Yang
Clinical Cancer Research 17 ( 17) 5783 -5792

71
2011
Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

Armin Gerger , Wu Zhang , Dongyun Yang , Pierre Bohanes
Clinical Cancer Research 17 ( 21) 6934 -6943

76
2011
Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence

David Páez , Melissa J. Labonte , Pierre Bohanes , Wu Zhang
Clinical Cancer Research 18 ( 3) 645 -653

134
2012
Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients

Thomas Winder , Wu Zhang , Dongyun Yang , Yan Ning
Clinical Cancer Research 16 ( 22) 5591 -5602

37
2010
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.

Siwen Hu-Lieskovan , Daniel Vallbohmer , Wu Zhang , Dongyun Yang
Clinical Cancer Research 17 ( 15) 5161 -5169

41
2011
Profiling of differentially expressed genes in right and left side mCRC patients using nCounter customized gene expression assay.

Wu Zhang , Chirstina Curtis , Sebastian Stintzing , Volker Heinemann
Journal of Clinical Oncology 33

2015
27
2007
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab

Wu Zhang , Michael Gordon , Oliver A. Press , Katrin Rhodes
Pharmacogenetics and Genomics 16 ( 7) 475 -483

118
2006
Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.

Wu Zhang , Michael Gordon , Heinz‐Josef Lenz
Annals of Medicine 38 ( 8) 545 -551

53
2006
Human‐specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression

Shoib S Siddiqui , Michael Vaill , Raymond Do , Naazneen Khan
FASEB BioAdvances 3 ( 2) 69 -82

2
2021
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.

Hiroyuki Arai , Yi Xiao , Fotios Loupakis , Natsuko Kawanishi
Journal for ImmunoTherapy of Cancer 8 ( 2) 1 -9

1
2020
Gender disparities in metastatic colorectal cancer survival.

Andrew Hendifar , Dongyun Yang , Felicitas Lenz , Georg Lurje
Clinical Cancer Research 15 ( 20) 6391 -6397

128
2009
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

Anne M. Schultheis , Georg Lurje , Katrin E. Rhodes , Wu Zhang
Clinical Cancer Research 14 ( 22) 7554 -7563

167
2008
Association of Methylenetetrahydrofolate Reductase Gene Polymorphisms and Sex-Specific Survival in Patients With Metastatic Colon Cancer

Wu Zhang , Oliver A. Press , Christopher A. Haiman , Dong Yun Yang
Journal of Clinical Oncology 25 ( 24) 3726 -3731

56
2007
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells

Michal A Stanczak , Shoib S Siddiqui , Marcel P Trefny , Daniela S Thommen
Journal of Clinical Investigation 128 ( 11) 4912 -4923

176
2018
Risk of tumor-related death in stage I-III colon cance based on gender and tumor location.

Robert D. Ladner , Michael Kahn , Dongyun Yang , Sebastian Stintzing
Journal of Clinical Oncology 31 ( 15_suppl) e14538 -e14538

2013